---

---

tags : Therapeutics    crawled date : 2022 - 02 - 08   

save search

---

Cognition Therapeutics to Participate in Panel during the BIO CEO & Investor Conference on the Development of Neurodegenerative Therapeutics
Published: 2022-02-08 (Crawled : 23:00) - globenewswire.com
CGTX | $1.84 61K |

| -55.56% | O: 0.48% H: 0.48% C: -1.2%
ceo conference therapeutics neurodegenerative

---

Werewolf Therapeutics to Present at the SVB Leerink Global Healthcare Conference
Published: 2022-02-08 (Crawled : 23:00) - globenewswire.com
HOWL | $5.87 1.8K |

Professional, Scientific, and T...

| -19.92% | O: -1.09% H: 0.0% C: -3.03%
health thc conference therapeutics svb leerink global

---

Soleno Therapeutics to Participate in the BIO CEO & Investor Conference
Published: 2022-02-08 (Crawled : 23:00) - globenewswire.com
SLNO 4 | $37.78 1.7% 6.9K |

Health Technology

| 10397.32% | O: 3.93% H: 0.11% C: -1.66%
ceo conference therapeutics

---

Marker Therapeutics to Host Clinical Program Update Conference Call and Webcast on Wednesday, February 16, 2022
Published: 2022-02-08 (Crawled : 23:00) - globenewswire.com
MRKR | $4.1002 2.1K |

Consumer Services

| 653.23% | O: 3.06% H: 8.53% C: 1.75%
day program conference therapeutics

---

Corcept Therapeutics to Announce Fourth Quarter and Full-year 2021 Financial Results, Provide Corporate Update and Host Conference Call
Published: 2022-02-08 (Crawled : 23:00) - globenewswire.com
CORT M | $22.85 0.84% 61K |

Health Technology

| 17.07% | O: 0.15% H: 0.9% C: -0.85%
financial results conference therapeutics results

---

Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-02-08 (Crawled : 23:00) - globenewswire.com
ITRM | $1.43 19K |

Health Technology

| 240.48% | O: 4.76% H: 3.61% C: 0.0%
therapeutics nasdaq report grant granted

---

PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Year-End 2021 Financial Results
Published: 2022-02-08 (Crawled : 20:00) - biospace.com/
PTCT | $25.005 1.28% 120K |

Health Technology

| -41.72% | O: -0.37% H: 2.63% C: 1.51%
financial results conference therapeutics results

---

Gain Therapeutics Presents Preclinical Data on its Structurally Targeted Allosteric Regulators in GBA1 Gaucher Disease
Published: 2022-02-08 (Crawled : 19:00) - biospace.com/
GANX | $3.15 10K |

Professional, Scientific, and T...

| -30.11% | O: -0.54% H: 2.09% C: -6.3%
therapeutics disease preclinical pre-clinical

---

Akero Therapeutics Completes Enrollment of Phase 2b HARMONY Study in Pre-Cirrhotic NASH Patients
Published: 2022-02-08 (Crawled : 19:00) - biospace.com/
AKRO | $20.72 1.02% 40K |

Health Technology

| 9.04% | O: 0.11% H: 1.01% C: 0.37%
phase 2 phase 2b therapeutics nash enroll

---

Healx and Ovid Therapeutics to Enter Strategic Partnership
Published: 2022-02-08 (Crawled : 19:00) - biospace.com/
OVID | $3.23 0.62% 19K |

Health Technology

| 10.31% | O: 1.37% H: 2.2% C: 1.69%
partnership therapeutics

---

Cyclo Therapeutics Selected to Present Overview of Pivotal Phase 3 Study for Lead Candidate, Trappsol® Cyclo™, at WORLDSymposium 2022
Published: 2022-02-08 (Crawled : 14:00) - biospace.com/
CYTH | $1.2 18 |

Professional, Scientific, and T...

| -66.01% | O: 3.4% H: 2.47% C: 1.64%
trappsol symposium therapeutics phase 3

---

ADC Therapeutics Highlights its Proprietary ADC Platform and Solid Tumor Pipeline
Published: 2022-02-08 (Crawled : 14:00) - biospace.com/
ADCT | $4.88 2.52% 77K |

Health Technology

| -70.89% | O: 1.47% H: 0.0% C: -1.39%
therapeutics platform

---

Outlook Therapeutics Expands Commercial Team with Appointment of Senior Vice President of Commercial Operations
Published: 2022-02-08 (Crawled : 13:30) - globenewswire.com
OTLK P | $8.375 1.03% 63K |

Health Technology

| 530.77% | O: -2.56% H: 0.75% C: 0.75%
therapeutics commercialization

---

Forma Therapeutics to Present at 11th Annual SVB Leerink Healthcare Conference
Published: 2022-02-08 (Crawled : 13:00) - biospace.com/
FMTX | $20.01 -0.15% |

Health Technology

| 80.0% | O: -2.43% H: 2.03% C: 0.55%
health thc conference therapeutics

---

Cyteir Therapeutics Announces First Patient Dosed in Phase 2 with CYT-0851
Published: 2022-02-08 (Crawled : 13:00) - biospace.com/
CYT | $3.02 2.65% 1M |

Manufacturing

| -49.92% | O: 2.82% H: 2.1% C: 1.29%
cyt-0851 phase 2 therapeutics

---

Stealth BioTherapeutics Announces Oral Presentation of New Duchenne Muscular Dystrophy Data at the 2022 Muscular Dystrophy Association Clinical and Scientific Conference
Published: 2022-02-08 (Crawled : 13:00) - prnewswire.com
MITO | $0.32 0.25% |

Health Technology

| -49.21% | O: 3.16% H: 1.49% C: -1.54%
muscular dystrophy ces conference therapeutics presentation duchenne iot

---

Sonnet BioTherapeutics Provides Fiscal Year 2022 First Quarter Business and Earnings Update
Published: 2022-02-08 (Crawled : 12:30) - biospace.com/
SONN | $1.79 1.13% 1.4K |

Health Technology

| 461.9% | O: 1.9% H: 0.0% C: -5.76%
therapeutics iot

---

CytomX Therapeutics Announces Promotion of Amy C. Peterson, M.D. to President and Chief Operating Officer
Published: 2022-02-07 (Crawled : 00:00) - biospace.com/
CTMX | $1.725 -0.29% 33K |

Health Technology

| -56.34% | O: 0.82% H: 0.0% C: 0.0%
BGNE | $129.675 -1.73% 45K |

Health Technology

| -40.09% | O: -0.27% H: 0.0% C: 0.0%
ces therapeutics

---

Gainers vs Losers

82%

18%

Top 10 Gainers

AGBA | News | $1.37 242.5% 76M |

Finance

EGOX | $0.0606 68.33% 250M |

CHRO | $1.73 41.22% 46K |

n/a

ZCMD | $1.98 36.55% 27M |

Commercial Services

RWOD | $10.61 32.68% 5.1M |

n/a

NVFY | $2.77 31.28% 2.2M |

Consumer Durables

AULT | $0.304 25.57% 47M |

Manufacturing

WISA 4 | $7.19 22.07% 18M |

Electronic Technology

MCB 4 | $39.53 19.43% 88K |

Finance

PRTG | $0.285 18.75% 170K |

Mining, Quarrying, and Oil and ...

---

Your saved searches

---